Biological Products, (No Diagnostic Substances) · DE · CIK 1501697
Develops and commercializes novel therapeutics for rare hematology diseases, including mavorixafor for WHIM syndrome and chronic neutropenia
Comparable business profile · signals at a glance
In the 90 days to Oct 23, 2025: 1 insider bought $250K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 23, 2025 | Craig Adam RExecutive Chairman | Buy | 86,206 | $2.90 | $250K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.